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Abstract
Background: Evidence in the literature suggests that exopolysaccharides (EPS) produced by bacterial cells are
essential for the expression of virulence in these organisms. Secreted EPSs form the framework in which microbial
biofilms are built.
Methods: This study evaluates the role of EPS in Prevotella intermedia for the expression of virulence. This
evaluation was accomplished by comparing EPS-producing P. intermedia strains 17 and OD1-16 with non-
producing P. intermedia ATCC 25611 and Porphyromonas gingivalis strains ATCC 33277, 381 and W83 for their
ability to induce abscess formation in mice and evade phagocytosis.
Results: EPS-producing P. intermedia strains 17 and OD1-16 induced highly noticeable abscess lesions in mice at
10
7 colony-forming units (CFU). In comparison, P. intermedia ATCC 25611 and P. gingivalis ATCC 33277, 381 and
W83, which all lacked the ability to produce viscous materials, required 100-fold more bacteria (10
9 CFU) in order
to induce detectable abscess lesions in mice. Regarding antiphagocytic activity, P. intermedia strains 17 and OD1-16
were rarely internalized by human polymorphonuclear leukocytes, but other strains were readily engulfed and
detected in the phagosomes of these phagocytes.
Conclusions: These results demonstrate that the production of EPS by P. intermedia strains 17 and OD1-16 could
contribute to the pathogenicity of this organism by conferring their ability to evade the host’s innate defence
response.
Background
Exopolysaccharide (EPS) productivities in many bacteria
have been associated with pathogenicity in mammalian
hosts as providing extracellular matrices to form biofilm
or capsular polysaccharides attached to the cell surface
[1-3]. Within biofilms, bacteria themselves are embedded
in EPS and organise as a multicellular community [4].
Many gram-positive and gram-negative bacteria also pro-
duce polysaccharides that remain attached to the cell to
form a capsule [5,6]. Some clinical isolates of Prevotella
intermedia and Prevotella nigrescens produce mannose-
rich EPSs. As revealed by electron microscopy, these clin-
ical isolates showed dense meshwork structures around
their cells [7,8], which are similar to the phenotype of
other biofilm-forming bacteria such as Pseudomonas
aeruginosa [9], salmonellae [10,11], Escherichia coli
[12,13], and Vibrio cholerae [14]. Like the mucoid type of
P. aeruginosa [15], these clinical isolates of P. intermedia
spontaneously produce EPS and form meshwork struc-
tures around their cells, even under planktonic growth
conditions [8]. EPS productivity is known to enhance the
virulence properties of otherwise innocuous or relatively
low virulent bacteria [7,8,16,17]. To determine the role of
EPS for the expression of virulence in P. intermedia,w e
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dia to the reference strain P. intermedia ATCC25611
and EPS non-producing strains of Porphyromonas gingi-
valis, the organism that is most strongly associated with
periodontal diseases.
Methods
Bacterial strains and cultures
EPS-producing P. intermedia 17 (Pi17) [8,18] and OD1-
16 (PiOD1-16: a viscous material-producing clinical iso-
late from a chronic periodontitis lesion identified by 16S
rRNA gene sequencing) were used in this study. We
examined the chemical composition of viscous materials
in PiOD1-16 culture supernatant and confirmed that this
organism produced mannose-rich EPSs whose chemical
composition is similar to those of Pi17 [8] (see below).
P. intermedia ATCC 25611 (Pi25611), P. gingivalis
ATCC 33277 (Pg33277), W83 (PgW83) and 381 (Pg381)
were used as reference strains to compare the bacteria’s
capacity to induce abscess formation in mice. These bac-
terial strains were grown on trypticase soy blood agar
plates supplemented with 0.5% yeast extract (Difco
Laboratories, Detroit, MI), hemin (5 mg/l), L-cystine
(400 mg/l), and vitamin K1 (10 mg/l) (enriched BAP) or
grown in trypticase soy broth (BBL Microbiology Sys-
tems, Cockeysville, ND) supplemented with 0.5% yeast
extract, hemin (5 mg/l), L-cystine (400 mg/l), and vitamin
K1 (10 mg/l) (enriched TSB). Bacterial cultures were
grown anaerobically in an anaerobic chamber (ANX-3,
H i r a s a w a ,T o k y o ,J a p a n )a t3 7 ° Ci na5 %C O 2,1 0 %H 2,
85% N2 atmosphere. Growth of the tested organisms in
enriched TSB was monitored by following the optical
density at 600 nm with U-2000 spectrophotometer (Hita-
chi, Tokyo, Japan).
Viscosity of spent culture media, cell surface structures
and chemical compositions of viscous materials
The ability to produce EPS in liquid culture media and
form meshwork structures on cell surfaces by the test bac-
teria was examined as described elsewhere [8]. Briefly, the
stock strains were grown in enriched TSB for 48 h. The
spent culture medium (550 μl) was put into a rotor, and
the viscosity was measured as shearing stress between a
rotor and a rotor shaft at 50 rpm, 20°C using a rotary visc-
ometer (Toki-sangyo, Tokyo, Japan). Five independent cul-
tures of each strain were measured and statistical
differences between the bacterial cultures and the control
medium were determined using an unpaired t-test with the
level of significance set at P < 0.05.
To examine cell surface structures, scanning electron
microscopy (SEM) was performed. Bacteria grown on
enriched BAP for 48 h were collected on a piece of filter
paper (Glass fiber GA55, ToyoR o s h i ,T o c h i g i ,J a p a n ) ,
fixed with 2% glutaraldehyde in 0.1 M phosphate buffer
(PB) for 2 h and 1% OsO4 in 0.1 M PB for 1 h at 4°C, and
dehydrated through an ethanol series and 2-methyl-2-
propanol followed by platinum ion coating (E-1030, Hita-
chi, Tokyo, Japan). Specimens were examined with a
scanning electron microscope (S-4800, Hitachi) at an
accelerating voltage of 3 kV.
The EPS was prepared from culture supernatants as
described [8]. In brief, OD1-16 was grown at 37°C in
enriched TSB for 48 h. Supernatants were separated by
centrifuging the liquid culture at 12,000 × g for 30 min,
and sodium acetate was added to a final concentration of
5%. The mixture was stirred for 30 min at 22°C, and the
EPS was isolated by ethanol precipitation from the reac-
tion mixture. The ethanol-precipitated material was col-
lected by centrifugation (18,200 × g for 15 min at 22°C),
resolved in 5% sodium acetate, and treated with chloro-
form: 1-butanol (1: 5 by volume). Water-soluble and
chloroform-butanol layer were separated by centrifugation,
an equal amount of ethanol was added to the water-solu-
ble layer (this procedure was repeated twice), and the etha-
nol-precipitated material was freeze-dried and stored at
-80°C until use [19]. Contaminated lipopolysaccharides
were removed from preparations by the method described
by Adam et al. [20].
The sugar composition of the purified viscous material
were determined by means of high performance liquid
chromatography (HPLC) for neutral and amino sugars
and colorimetry for uronic acid as detailed elsewhere [8].
Animal studies
The virulence of EPS-producing clinical isolates of
P. intermedia was compared with those of Pi25611,
Pg33277, Pg W83 and Pg 381. Bacterial strains were cul-
t u r e di ne n r i c h e dT S Bf o r3 2hf o rPi17 and PiOD1-16
and for 24 h for Pi25611, Pg33277, PgW83 and Pg381
(early stationary phase). The inguen of each BALB/c
mouse (male, 4 weeks; 5 mice per strain) was injected sub-
cutaneously with 500 μl of bacterial suspensions (10
7 to
10
10 CFU). Changes of abscess lesions were recorded
photographically with a camera set (Nikon FIII, Nikon,
Japan) at a fixed magnification for 5 consecutive days.
Abscess areas recorded on the third day were measured
and analyzed with image analysis software (Image Mea-
sure; Imsoft, Tokyo, Japan). The experiments were per-
formed twice. The animal studies were done according to
the guidelines for animal experimentation at Osaka Dental
University.
Phagocytosis assay
To compare antiphagocytic activity among the strains
used in this study, bacterial cells were co-cultured with
polymorphonuclear leukocytes (PMNLs) obtained from
healthy human volunteers (n = 3; age 20-23 years) as
described previously [8]. After incubation for 90 min,
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Page 2 of 10PMNLs co-cultured with bacterial cells were centrifuged;
and cell pellets were fixed with 2% glutaraldehyde in 0.1
MP Bf o r2ha t4 ° C ,p o s t - f i x e dw i t h1 %O s O 4 in 0.1 M
PB for 1 h at 4°C, and dehydrated through an ethanol ser-
ies. Samples were embedded in epoxy resin and cut at
60-80 nm using an Ultracut (Leica, Tokyo, Japan). The
sections were placed on a copper grid, contrasted with
uranyl acetate and lead citrate, and examined under an
H-7100 transmission electron microscope (Hitachi,
Tokyo, Japan).
Localization of bacteria in vivo
To examine the localization of bacterial cells in vivo,1 0
8
CFU of PiOD1-16, Pi25611 and Pg33277 were injected
into the inguinal region of mice as described above.
Mice were sacrificed at 48 h after the injection, and the
regions where bacterial cell suspension was given were
dissected under a stereoscopic microscope (Nikon,
Tokyo, Japan). The specimens were cut into rectangular
strips measuring 2 × 2 × 5 mm and fixed by immersion
fixation in 2% glutaraldehyde for 2 h at 4°C, rinsed three
times with 0.1 M PB, and post-fixed with 1% OsO4 in
0.1 M PB. Ultrathin sections were prepared for trans-
mission electron microscopy (TEM) as described above.
Results
Viscosity of spent culture media and cell surface
meshwork structures
Our stock strains of EPS-producing Pi17 and PiOD1-16
showed higher viscosity in their spent culture media than
those of other periodontopathic bacteria used in this study
(Figure 1). The viscosity of t h es p e n tc u l t u r em e d i ao f
Pi25611, Pg33277, Pg381 and PgW83 was similar to that
of the control medium without bacterial inoculation
(Figure 1). SEM observation revealed that Pi17 and
PiOD1-16 maintained the ability to form dense meshwork
structures around their cells (Figure 2). Typical meshwork
structures were not observed around other strains
although Pi25611, Pg33277 and Pg381 showed intercellular
net structures (Figure 2). Growth of strains with EPS pro-
duction (Pi17 and PiOD1-16) was slower than that of EPS
non-producing strains. Pi17 and PiOD1-16 entered into
exponential phase at around 18 h and reached plateau
(stationary phase) in 32 h. Other strains that did not pro-
duce viscous material showed faster growth, entering into
an exponential phase at 12 h and reaching plateau in 24 h
(Figure 3).
Chemical compositions of PiOD1-16 EPS
Chemical analyses of the purified EPS from PiOD1-16
cultures showed that it primarily consisted of neutral
sugars and small amounts of uronic acid and amino
sugars, with mannose constituting 82% of the polysac-
charides (Table 1).
Abscess induction in mice
The abilities of Pi17 and PiOD1-16 to induce abscesses in
mice were compared to those of other laboratory reference
strains. The injections of 10
7 CFU of Pi17 and PiOD1-16
induced abscesses in mice, respectively (Figure 4). In con-
trast, injections of a similar amount of Pi25611, Pg33277,
Pg381 and PgW83 at the same growth phase failed to
induce abscesses in mice. A much higher cell concentra-
tion (10
9-10
10 CFU) was required to induce abscesses in
mice for these reference strains (Figure 4). The bacteria
dose of 10
10 CFU was lethal at 24 h after the injection for
all strains except Pg33277 and Pg381 (Table 2).
Phagocytosis assay with human PMNLs
Next, we addressed whether P. intermedia with EPS pro-
duction is resistant to phagocytosis by human PMNLs in
vitro.I nc o n t r a s tt oPi17 and PiOD1-16 that were rarely
internalized, other test strains were readily internalized
by human PMNLs, namely six bacterial cells on an aver-
age were found in cytoplasmic vacuoles of each PMNL as
revealed by TEM (Figure 5 and 6).
Localization of bacteria in vivo
To further investigate the antiphagocytic effect of EPS in
vivo,1 0
8 CFU of PiOD1-16, Pi25611 and Pg33277 were
injected into inguinal regions of mice, and the localization
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Figure 1 Viscosity of the spent culture media obtained from
Prevotella intermedia strains 17, OD1-16 and ATCC 25611 and
Porphyromonas gingivalis strains ATCC 33277, 381 and W83.
Viscosity of the enriched trypticase soy broth was measured as a
control. Bars indicate standard deviations. *P < 0.05.
Yamanaka et al. BMC Infectious Diseases 2011, 11:228
http://www.biomedcentral.com/1471-2334/11/228
Page 3 of 10of bacterial cells was observed by TEM. In the murine tis-
sues, bacterial cells of PiOD1-16 were observed around
PMNLs but rarely internalized (Figure 7A and 7B). In con-
trast, Pi25611 and Pg33277 cells were readily internalized
and localized inside phagosomes (Figure 7C to 7F).
Discussion
P. intermedia and the related P. nigrescens are known as
periodontopathic bacteria and frequently isolated not
only from various types of periodontal diseases [21-23]
but infections in infants [24] and sinusitis lesions of den-
tal origin [25]. Previously, we reported that clinical
strains of P. nigrescens [7] and P. intermedia [8] isolated
from chronic periodontitis lesions produce viscous mate-
rials under planktonic growth conditions. These materi-
als form dense meshwork structures on cell surfaces as
illustrated by SEM. Chemical analyses of the viscous
materials isolated from their culture supernatants
C D
E F
A B
Figure 2 Scanning electron micrographs showing surface structures of Prevotella intermedia strains 17 (A), OD1-16 (B) and ATCC
25611 (C) and Porphyromonas gingivalis ATCC 33277 (D), 381 (E) and W83 (F) grown on blood agar plates. P. intermedia strains 17 and
OD1-16 had dense meshwork structures surrounding the cell surfaces (A and B), but other strains lacked this phenotype. Bars = 1.2 μm.
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Page 4 of 10revealed that they consisted of mostly neutral sugars with
mannose constituting more than 80% of the polysacchar-
ide. Purified EPS itself did not exhibit any pathogenicity
or immunogenicity. However, whole cells of clinical
strains capable of producing EPS, in comparison to EPS
non-producing mutants, show a strong ability to induce
abscess in mice [7,8]. Interestingly, the virulence of the
mutants to induce abscess in mice can be restored by co-
application of the variants with the purified EPS [7].
Therefore, EPS could represent a key component contri-
buting to the virulence of P. intermedia and P. nigrescens.
Our finding is consistent with the findings of P. aerugi-
nosa as reported previously [26]. In this regard, Deighton
et al. [17] compared the virulence of slime-positive Sta-
phylococcus epidermidis with that of a slime-negative
strain in a mouse model of subcutaneous infection and
showed that biofilm-positive strains produce significantly
more abscesses and persisted longer in the infection.
To further evaluate the level of pathogenicity on the
clinical strains of P. intermedia with EPS productivity,
this study compared the ability of EPS-producing
P. intermedia and several laboratory reference strains of
periodontopathic bacteria (Pi25611, Pg33277, Pg381 and
PgW83) to induce abscess formation in mice. EPS-
producing Pi17 and PiOD1-16 induced abscess lesions
in mice at 10
7 CFU, but other test periodontopathic
bacteria did not when tested at this cell concentration.
Pi25611 and P. gingivalis strains used in this study
induced detectable abscess formation in mice when the
infectious dose was 10
9 CFU and higher. The abscess
model in mice with inoculum sizes of 10
9-10
10 CFU has
been used to demonstrate the biological activities of
P. gingivalis [27,28]. Accordingly, the pathogenicity of
Pi17 and PiOD1-16 appeared to be stronger than those
of the P. gingivalis strains as well as the ATCC strain of
P. intermedia used in this study.
A wide range of microorganisms is known to produce
EPS as a main constituent of the biofilm extracellular
matrix, and recent investigations have revealed that each
biofilm-forming bacterium produces distinctive EPS com-
ponents [29]. In oral microbiota, Capnocytophaga ochra-
cea found in the human oral cavity has been shown to
produce mannose-rich EPS that can suppress murine lym-
phocyte mitogen responses and activate human comple-
ment response [30-32]. Kapran et al. [33] reported that
Aggregatibacter actinomycetemcomitans has a gene cluster
which is homologous to E. coli pgaABCD and encodes the
production of poly-ß-1,6-GlcNAc (PGA) [34]. Rothia
mucilaginosa DY-18 [35] and Escherichia hermannii YS-
11 [36] isolated from persistent apical periodontitis lesions
produced EPS and exhibited cell surface meshwork struc-
tures. The meshwork structures of E. hermannii YS-11
disappeared when wzt, one of the ABC-transporter genes,
was disrupted by transposon random insertion mutagen-
esis. Complementation of this gene to the transposant
restored and dramatically augmented the formation of
meshwork structures. Our studies using an abscess model
in mice indicated that this EPS phenotype might be
involved in the pathogenicity of this organism [36]. Like-
wise, as described above, EPS productivity could be asso-
ciated with P. intermedia and P. nigrescens pathogenicity
[7,8].
In our experience, more than 20% of clinically isolated
P. intermedia strains showed viscous material productiv-
ity under planktonic growth conditions [18]. This ability
was lost in the course of sequential in vitro passage. As a
result, less than 2% of clinical isolates remained as vis-
cous material-producing strains (data not shown). There-
fore, it is important to note that laboratory reference
strains do not always represent the original virulence
properties as Fux et al. [37] previously pointed out. Early
studies have pointed out the relation between bacterial
pathogenicity and polysaccharide productivity on the
reference strains used in this study. Okuda et al. [38]
reported that Pi25611, Pg381 and Pg33277 had capsular
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Figure 3 Growths of test strains. Prevotella intermedia strains 17
(black square) and OD1-16 (open circle) showed a slower growth
rate, entering into an exponential phase at around 18 h and
reaching the plateau in 32 h, than those of P. intermedia ATCC
25611 (open rhombus), Porphyromonas gingivalis ATCC 33277 (black
star), 381 (open triangle) and W83 (black circle).
Table 1 Amount of neutral sugar, neutral sugar
components, uronic acid and amino-sugar in the viscous
material isolated from culture supernatants of Prevotella
intermedia OD1-16
Sugar Amount (μg/mg)
Neutral sugar 791.7
Mannose 682.1
Glucose 50.1
Galactose 30.3
Arabinose 16.4
Xylose 7.9
Uronic acid 27.7
Aminosugar 13.7
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Page 5 of 10structures around the cells and that the capsular polysac-
charides extracted from Pg381 contained galactose and
glucose as their major constituents. PgW83 is known to
produce capsular polysaccharides, and the genetic locus
for capsule biosynthesis has been identified [39,40]. As
discussed in these earlier studies [38,41-44], cell surface-
associated polysaccharides could represent another set of
virulence factors in additiont op r o d u c t i o no fv a r i o u s
proteolytic enzymes, contributing to the pathogenicity of
P. gingivalis strains. In this study, we did not detect the
107
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Figure 4 Abscess induction in mice. Abscess formation was induced when 0.5 ml of bacterial cell suspension (2 × 10
7 CFU/ml) of Prevotella
intermedia strains 17 and OD1-16 was injected into the inguinal area of a mouse. In contrast, subcutaneously injected P. intermedia ATCC 25611,
Porphyromonas gingivalis ATCC 33277, 381 and W83 (0.5 ml at a concentration of 2 × 10
8 CFU/ml) failed to induce an abscess in the mice. When
these strains were injected at a higher concentration (2 × 10
9 CFU/ml), abscess formation was ultimately induced. The data are representative
from one of two independent experiments.
Table 2 Abscess area and lethality
Bacteria Mean abscess area ± standard deviation
1 and lethality
2
Infectious dose (CFU)
10
7 10
8 10
9 10
10
Prevotella intermedia
Strain 17 19.5 ± 10.9 (0/10) 102.9 ± 56.1 (0/10) Lethal (10/10) Lethal (10/10)
OD1-16 15.9 ± 5.9 (0/10) 87.0 ± 59.5 (0/10) 292.3 ± 79.7 (8/10) Lethal (10/10)
ATCC 25611 ND (0/10) ND (0/10) 222.9 ± 83.5 (2/10) Lethal (10/10)
Porphyromonas gingivalis
ATCC 33277 ND (0/10) ND (0/10) 191.7 ± 54.7 (0/10) 237.9 ± 59.8 (4/10)
381 ND (0/10) ND (0/10) 242.1 ± 72.5 (0/10) 278.6 ± 122.5 (4/10)
W83 ND (0/10) ND (0/10) 259.5 ± 97.4 (4/10) Lethal (10/10)
1Abscess area was measured at 3 days after the injection.
2Motality of mice 24 h after the injection is shown in parentheses.
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Page 6 of 10presence of capsular polysaccharide or production of EPS
in P. gingivalis strains. One possibility is that the tested
P. gingivalis strains had lost their ability to produce cap-
sular polysaccharides or EPS because of multiple in vitro
passages of the organisms in the laboratory. Further,
none of these strains regained capsular polysaccharides
or EPS productivity through repetitive animal passages
(data not shown). This could explain the less virulent
characteristics displayed by the tested P. gingivalis strains
shown in our animal virulence experiments.
As our [7,8] and other earlier studies [26,45] indicated, it
is plausible that the antiphagocytic effect of EPS confers the
ability to P. intermedia to induce abscess. It has been
demonstrated that the slime or components of slime from
S. epidermidis cultures could contribute to the delay of
clearance of this organism from host tissues. Similarly, in
the murine model of systemic infection, the deletion of ica
locus necessary for the biosynthesis of surface polysacchar-
ide of Staphylococcus aureus significantly reduces its viru-
lence [45]. As described above, a study in the early 1970s
clearly showed that the addition of slime from P. aeruginosa
A
B
C
Figure 5 Resistance of viscous material-producing Prevotella
intermedia strain OD1-16 against the phagocytic activity of
human polymorphonuclear leukocytes in vitro. P. intermedia OD1-
16 cells were observed around the periphery of polymorphonuclear
leukocyte but not internalized (A, arrow heads). In contrast,
P. intermedia ATCC 25611 and Porphyromonas gingivalis ATCC 33277
cells without viscous material production were readily internalized and
the ingested bacteria appear to be enclosed in cytoplasmic vacuoles
(B and C, open stars). The data are representative from one of three
independent experiments. Bars = 3.3 μm.
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Figure 6 Number of bacterial cells engulfed in a
polymorphonuclear leukocyte (PMNL). Under transmission
electron microscopy (TEM), 30 PMNLs were arbitrarily selected, and
the number of bacterial cells engulfed in each cell was counted.
The results show the average number and standard deviation for
the number of bacterial cells engulfed in each PMNL. Statistical
difference to Prevotella intermedia ATCC 25611 was determined
using unpaired t-test with the significance set at P < 0.05 (*).
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Page 7 of 10cultures to E. coli or S. aureus dramatically inhibited phago-
cytosis by leukocytes [26]. In this study, EPS-producing
Pi17 and PiOD1-16 cells were rarely internalized by leuko-
cytes both in vitro and in vivo. Many of these bacteria were
seen localized to the cell surface of PMNLs but failed to be
ingested. In such a situation, PMNLs are known to produce
a harmful effect to the surrounding tissue by elaborating a
variety of degradative enzymes and oxygen radicals in an
attempt to clear the invaded pathogens [46,47]. In contrast,
the test laboratory reference strains of periodontopathic
bacteria, lacking EPS production, were readily engulfed and
digested in phagosomes of phagocytes.
Most pathogenic P. gingivalis strains exhibit a higher
resistance to phagocytosis than less pathogenic strains do
[48]. In our study, the P. gingivalis strains were readily
phagocytosed. It has been documented that freshly iso-
lated pathogenic strains of P. gingivalis could lose invasive-
ness as a result of repeated subcultures [44]. Therefore, it
is reasonable to speculate that pathogenic P. gingivalis
strains become less pathogenic and more susceptible to
phagocytosis by PMNLs when they lose the ability to pro-
duce capsular or extracellular polysaccharides though we
have to carefully investigate the possibility that multiple
factors exist in the observed incapability to induce
abscesses in mice. We have not been able to restore any of
our working strains of P. gingivalis’ ability to express cell
surface-associated meshwork structures or the ability to
spontaneously produce viscous material in spent culture
media. It is still unclear whether P. gingivalis with capsule
formation or EPS productivity exhibits similar or higher
pathogenicity to those of P. intermedia strains with mesh-
work structures.
Conclusions
The data obtained in this study suggest that the patho-
genicity of P. intermedia with the ability to produce EPS
might be stronger than those of the P. gingivalis strains
as well as the ATCC strain of P. intermedia that lack the
ability to produce viscous materials. It is important to
point out that freshly isolated clinical strains are needed
OD1-16 ATCC 25611
A C
BD
E
F
ATCC 33277
Figure 7 Resistance of viscous material-producing Prevotella intermedia strain OD1-16 against the phagocytic activity of murine
polymorphonuclear leukocytes (PMNLs) in vivo. P. intermedia OD1-16 cells were not internalized by PMNLs (A and B, arrows). In contrast,
P. intermedia ATCC 25611 and Porphyromonas gingivalis ATCC 33277 cells were ingested and digested in phagolysosomes (C-F, open stars). The
data are representative from one of two independent experiments. Bars = 3.3 μm (A, C, and E) and 1.2 μm (B, D, and F).
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Page 8 of 10to re-evaluate the pathogenicity of periodontopathic bac-
teria isolated from the dental plaque or periodontal
lesions because many virulence phenotypes expressed in
natural environmental niches could be lost through mul-
tiple laboratory passages.
The authors declare that they have no competing
interests.
Acknowledgements
We are grateful to Mr. Hideaki Hori (the Institute of Dental Research, Osaka
Dental University) for his excellent assistance with electron microscopy. A
part of this research was performed at the Institute of Dental Research,
Osaka Dental University. This study was supported in part by Osaka Dental
University Joint Research Funds (B08-01).
Author details
1Department of Bacteriology, Osaka Dental University, 8-1 Kuzuha-Hanazono,
Hirakata, 573-1121 Japan.
2Department of Oral Biology, College of Dentistry,
University of Florida, Box 100424 UF Health Science Center, Gainesville, FL
32610-0424, USA.
3US Army Dental and Trauma Research Detachment,
Institute of Surgical Research, 3650 Chambers Pass, Fort Sam Houston, TX
78234-6315, USA.
Authors’ contributions
TY, TF and CM carried out the phenotype characterization and drafted the
manuscript. TY, KY, CS, TN and NO performed animal studies and
phagocytosis assays. CBW, KPL, and HF participated in the design of this
study and drafted the manuscript. All authors read and approved the final
manuscript.
Received: 13 April 2011 Accepted: 25 August 2011
Published: 25 August 2011
References
1. Sutherland IW: Bacterial exopolysaccharides. Adv Microb Physiol 1972,
8:143-213.
2. Costerton JW, Irvin RT, Cheng KJ: The bacterial glycocalyx in nature and
disease. Annu Rev Microbiol 1981, 35:299-324.
3. Costerton JW, Irvin RT, Cheng KJ: The role of bacterial surface structures
in pathogenesis. Crit Rev Microbiol 1981, 8(4):303-338.
4. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM:
Microbial biofilms. Annu Rev Microbiol 1995, 49:711-745.
5. Botta GA, Arzese A, Minisini R, Trani G: Role of structural and extracellular
virulence factors in gram-negative anaerobic bacteria. Clin Infect Dis 1994,
18(Suppl 4):S260-264.
6. Reeves PR, Hobbs M, Valvano MA, Skurnik M, Whitfield C, Coplin D, Kido N,
Klena J, Maskell D, Raetz CRH, Rick PD: Bacterial polysaccharide synthesis
and gene nomenclature. Trends Microbiol 1996, 4(12):495-503.
7. Yamane K, Yamanaka T, Yamamoto N, Furukawa T, Fukushima H, Walker CB,
Leung K-P: A novel exopolysaccharide from a clinical isolate of Prevotella
nigrescens: purification, chemical characterization and possible role in
modifying human leukocyte phagocytosis. Oral Microbiol Immunol 2005,
20(1):1-9.
8. Yamanaka T, Furukawa T, Matsumoto-Mashimo C, Yamane K, Sugimori C,
Nambu T, Mori N, Nishikawa H, Walker CB, Leung K-P, Fukushima H: Gene
expression profile and pathogenicity of biofilm-forming Prevotella
intermedia strain 17. BMC Microbiol 2009, 9(1):11.
9. Dunne WM Jr, Buckmire FLA, Kushnaryov VM: Comparative ultrastructure
of a mucoid strain of Pseudomonas aeruginosa isolated from cystic
fibrosis patient and its spontaneous non-mucoid mutant. Microbios 1982,
34(137-138):197-212.
10. Romling U, Sierralta WD, Eriksson K, Normark S: Multicellular and
aggregative behaviour of Salmonella typhimurium strains is controlled
by mutations in the agfD promoter. Molecular Microbiology 1998,
28(2):249-264.
11. Jain S, Chen J: Antibiotic resistance profiles and cell surface components
of salmonellae. J Food Prot 2006, 69(5):1017-1023.
12. Prigent-Combaret C, Prensier G, Le Thi TT, Vidal O, Lejeune P, Dorel C:
Developmental pathway for biofilm formation in curli-producing
Escherichia coli strains: role of flagella, curli and colanic acid. Environ
Microbiol 2000, 2(4):450-464.
13. Uhlich GA, Cooke PH, Solomon EB: Analyses of the red-dry-rough
phenotype of an Escherichia coli O157:H7 strain and its role in biofilm
formation and resistance to antibacterial agents. Appl Environ Microbiol
2006, 72(4):2564-2572.
14. Wai SN, Mizunoe Y, Takade A, Kawabata S-I, Yoshida S-I: Vibrio cholerae O1
strain TSI-4 produces the exopolysaccharide materials that determine
colony morphology, stress resistance, and biofilm formation. Appl Environ
Microbiol 1998, 64(10):3648-3655.
15. Kobayashi H: Airway biofilm disease: clinical manifestations and
therapeutic possibilities using macrolides. J Infect Chemother 1995, 1:1-15.
16. Yu H, Boucher JC, Hibler NS, Deretic V: Virulence properties of
Pseudomonas aeruginosa lacking the extreme- stress sigma factor AlgU
(σ
E). Infect Immun 1996, 64(7):2774-2781.
17. Deighton MA, Borland R, Capstick JA: Virulence of Staphylococcus
epidermidis in a mouse model: significance of extracellular slime.
Epidemiol Infect 1996, 117(2):267-280.
18. Fukushima H, Moroi H, Inoue J, Onoe T, Ezaki T, Yabuuchi E, Leung KP,
Walker CB, Clark WB, Sagawa H: Phenotypic characteristics and DNA
relatedness in Prevotella intermedia and similar organisms. Oral Microbiol
Immunol 1992, 7(1):60-64.
19. Campbell JH, Pappenheimer AM: Quantitative studies of the specificity of
anti-pneumococcal polysaccharide antibodies, types 3 and 8. II.
Inhibition of precipitin reactions with oligosaccharides isolated from
hydrolysates of S3 and S8. Immunochemistry 1966, 3(3):213-222.
20. Adam O, Vercellone A, Paul F, Monsan PF, Puzo G: A nondegradative route
for the removal of endotoxin from exopolysaccharides. Anal Biochem
1995, 225(2):321-327.
21. Dahlen GG: Black-pigmented gram-negative anaerobes in periodontitis.
FEMS Immunol Med Microbiol 1993, 6(2-3):181-192.
22. Bogen G, Slots J: Black-pigmented anaerobic rods in closed periapical
lesions. Int Endod J 1999, 32(3):204-210.
23. Baumgartner JC, Watkins BJ, Bae KS, Xia T: Association of black-pigmented
bacteria with endodontic infections. J Endod 1999, 25(6):413-415.
24. Brook I: Prevotella and Porphyromonas infections in children. J Med
Microbiol 1995, 42(5):340-347.
25. Brook I: Microbiology of intracranial abscesses associated with sinusitis
of odontogenic origin. Ann Otol Rhinol Laryngol 2006, 115(12):917-920.
26. Schwarzmann S, Boring JR III: Antiphagocytic effect of slime from a
mucoid strain of Pseudomonas aeruginosa. Infect Immun 1971, 3:762-767.
27. Alayan J, Gemmell E, Ford P, Hamlet S, Bird PS, Ivanovski S, Farah CS: The
role of cytokines in a Porphyromonas gingivalis-induced murine abscess
model. Oral Microbiol Immunol 2007, 22(5):304-312.
28. Nakano K, Kuboniwa M, Nakagawa I, Yamamura T, Nomura R, Okahashi N,
Ooshima T, Amano A: Comparison of inflammatory changes caused by
Porphyromonas gingivalis with distinct fimA genotypes in a mouse
abscess model. Oral Microbiol Immunol 2004, 19(3):205-209.
29. Branda SS, Vik S, Friedman L, Kolter R: Biofilms: the matrix revisited. Trends
Microbiol 2005, 13(1):20-26.
30. Dyer JK, Bolton RW: Purification and chemical characterization of an
exopolysaccharide isolated from Capnocytophaga ochracea. Can J
Microbiol 1985, 31(1):1-5.
31. Bolton RW, Dyer JK: Suppression of murine lymphocyte mitogen
responses by exopolysaccharide from Capnocytophaga ochracea. Infect
Immun 1983, 39(1):476-479.
32. Bolton RW, Dyer JK: Human complement activation by purified
Capnocytophaga exopolysaccharide. Measurement by
radioimmunoassay. J Periodontal Res 1986, 21(6):634-639.
33. Kaplan JB, Velliyagounder K, Ragunath C, Rohde H, Mack D, Knobloch JK,
Ramasubbu N: Genes involved in the synthesis and degradation of
matrix polysaccharide in Actinobacillus actinomycetemcomitans and
Actinobacillus pleuropneumoniae biofilms. J Bacteriol 2004,
186(24):8213-8220.
34. Wang X, Preston JF, Romeo T: The pgaABCD locus of Escherichia coli
promotes the synthesis of a polysaccharide adhesin required for biofilm
formation. J Bacteriol 2004, 186(9):2724-2734.
35. Yamane K, Nambu T, Yamanaka T, Mashimo C, Sugimori C, Leung K-P,
Fukushima H: Complete genome sequence of Rothia mucilaginosa DY-18:
Yamanaka et al. BMC Infectious Diseases 2011, 11:228
http://www.biomedcentral.com/1471-2334/11/228
Page 9 of 10a clinical isolate with dense meshwork-like structures from a persistent
apical periodontitis lesion. Sequencing 2010, 2010(Article ID 457236):1-6.
36. Yamanaka T, Sumita-Sasazaki Y, Sugimori C, Matsumoto-Mashimo C,
Yamane K, Mizukawa K, Yoshida M, Hayashi H, Nambu T, Leung K-P,
Fukushima H: Biofilm-like structures and pathogenicity of Escherichia
hermannii YS-11, a clinical isolate from a persistent apical periodontitis
lesion. FEMS Immunol Med Microbiol 2010, 59(3):456-465.
37. Fux CA, Shirtliff M, Stoodley P, Costerton JW: Can laboratory reference
strains mirror ‘real-world’ pathogenesis? Trends in Microbiol 2005,
13(2):58-63.
38. Okuda K, Fukumoto Y, Takazoe I, Slots J, Genco RJ: Capsular structures of
black-pigmented Bacteroides isolated from human. Bull Tokyo dent Coll
1987, 28(1):1-11.
39. Aduse-Opoku J, Slaney JM, Hashim A, Gallagher A, Gallagher RP,
Rangarajan M, Boutaga K, Laine ML, Van Winkelhoff AJ, Curtis MA:
Identification and characterization of the capsular polysaccharide (K-
Antigen) locus of Porphyromonas gingivalis. Infect Immun 2006,
74(1):449-460.
40. Davey ME, Duncan MJ: Enhanced biofilm formation and loss of capsule
synthesis: deletion of a putative glycosyltransferase in Porphyromonas
gingivalis. J Bacteriol 2006, 188(15):5510-5523.
41. Woo DDL, Holt SC, Leadbetter ER: Ultrastructure of Bacteroides species
Bacteroides asaccharolyticus, Bacteroides fragilis, Bacteroides
melaninogenicus subspecies melaninogenicus, and B. melaninogenicus
subspecies intermedius. J Infect Dis 1979, 139(5):534-546.
42. Yamamoto A, Takahashi M, Takamori K, Sasaki T: Ultrastructure of the
outer membrane surface of black-pigmented Bacteroides isolated from
human oral cavity. Bull Tokyo dent Coll 1982, 23(1):47-60.
43. Listgarten MA, Lai C-H: Comparative ultrastructure of Bacteroides
melaninogenicus subspecies. J Periodontal Res 1979, 14(4):332-340.
44. Neiders ME, Chen PB, Suido H, Reynolds HS, Zambon JJ, Shlossman M,
Genco RJ: Heterogeneity of virulence among strains of Bacteroides
gingivalis. J Periodontal Res 1989, 24(3):192-198.
45. Kropec A, Maira-Litran T, Jefferson KK, Grout M, Cramton SE, Gotz F,
Goldmann DA, Pier GB: Poly-N-acetylglucosamine production in
Staphylococcus aureus is essential for virulence in murine models of
systemic infection. Infect Immun 2005, 73(10):6868-6876.
46. Bjarnsholt T, Kirketerp-Moller K, Jensen PO, Madsen KG, Phipps R, Krogfelt K,
Hoiby N, Givskov M: Why chronic wounds will not heal: a novel
hypothesis. Wound Rep Reg 2008, 16(1):2-10.
47. Papayannopoulos V, Zychlinsky A: NETs: a new strategy for using old
weapons. Trends in Immunol 2009, 30(11):513-521.
48. Slots J, Genco RJ: Black-pigmented Bacteroides species, Capnocytophaga
species, and Actinobacillus actinomycetemcomitans in human periodontal
disease: virulence factors in colonization, survival, and tissue destruction.
J Dent Res 1984, 63(3):412-421.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2334/11/228/prepub
doi:10.1186/1471-2334-11-228
Cite this article as: Yamanaka et al.: Comparison of the virulence of
exopolysaccharide-producing Prevotella intermedia to exopolysaccharide
non-producing periodontopathic organisms. BMC Infectious Diseases 2011
11:228.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Yamanaka et al. BMC Infectious Diseases 2011, 11:228
http://www.biomedcentral.com/1471-2334/11/228
Page 10 of 10